The expression profile of PKC isoforms during MC3T3-E1 differentiation

International Journal of Molecular Medicine

Volumn 17, Issue 6, 2006, Pages 1125-1131

  Lampasso, Judith D ^a   Chen, Wen ^a   Marzec, N ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Bone sialoprotein; Differentiation; MC3T3 E1; Osteoblast; Protein kinase C isoform

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BIOLOGICAL MARKER; IMIDAZOLE DERIVATIVE; ISOPROTEIN; MESSENGER RNA; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE; OSTEOBLAST; PROTEIN TRANSPORT;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; IMIDAZOLES; MICE; OSTEOBLASTS; OSTEOGENESIS; PROTEIN ISOFORMS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PYRIDINES; RNA, MESSENGER;

EID: 33745713602     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.6.1125     Document Type: Article

References (36)

1. Choi JY, Lee BH, Song KB, Park RW, Kim IS, Sohn KY, Jo JS and Ryoo HM: Expression patterns of bone-related proteins during osteoblastic differentiation in MC33T3-E1 cells. J Cell Biochem 61: 609-618, 1996.
2. Quarles LD, Yohay DA, Lever LW, Caton R and Wenstrup RJ: Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development. J Bone Miner Res 7: 683-692, 1992.
3. Sudo H, Kodama H, Amagai Y, Yamamoto Y and Kasai S: In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96: 191-198, 1983.
4. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy, M, Pockwinse S, Lian JB and Stein GS: Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143: 420-430, 1990.
5. Kitching R, Qi S, Li V, Raouf A, Vary CP and Seth A: Coordinate gene expression patterns during osteoblast maturation and retinoic acid treatment of MC3T3-E1 cells. J Bone Miner Res 20: 269-280, 2002. (Pubitemid 41184324)
6. Higuchi CM, Hashimoto N, Kuriyama K, Yoshioka K, Yoshikawa H and Itoh K: Continous inhibition of MAPK signaling promotes the early differentiation and mineralization of the extra cellular matrix. J Bone Miner Res 18: 67-77, 2002.
7. Engelman JA, Lisanti MP and Scherer PE: Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 273: 32111-32120, 1998. (Pubitemid 29177155)
8. Zester A, Gredinger E and Bengal E: p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem 274: 5193-5200, 1999.
9. Suzuki A, Palmer G, Bonjour JP and Caverzasio J: Regulation of alkaline phosphatase activity by p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology 140: 3177-3182, 1999.
10. Vinals F, Lopez-Rovira T, Rosa JL and Ventura F: Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. FEBS 510: 99-104, 2002. (Pubitemid 34084891)
11. Dziak R, Dahman M and Lampasso J: Osteoblastic cell differentiation and p38 MAP kinase. Bone 36: S287, 2005.
12. Munakata M, Stamm C, Friehs I, Zurakowski D, Cowan DB, Cao-Danh H, McGowan FX Jr and Del Nido PJ: Protective effects of protein kinase C during myocardial ischemia require activation of phosphatidyl-inosiitol specific phospholipase C. Ann Thorac Surg 73: 1236-1245, 2002.
13. Denning MF, Dlugosz AA, Cheng C, Dempsey PJ, Coffey RJ Jr, Threadgill DW, Magnuson T and Yuspa SH: Cross-talk between epidermal growth factor receptor and protein kinase C during calcium-induced differentiation of keratinocytes. Exp Derm 9: 192-199, 2000.
14. Wetsel WC, Khan WA, Merchenthaler I, Rivera H, Halpern AE, Phung HM, Negro-Vilar A and Hannun YA: Tissue and cellular distribution of the extended family of Protein kinase C isoenzymes. J Cell Biol 117: 121-133, 1992.
15. Brandlin I, Hubner S, Eiseler T, Martinez-Moya M, Hausser A, Horschinek A, Link G, Rupp S, Storz P, Pfizenmaier K and Johannes FJ: Protein kinase C (PKC) eta-mediated mu activation modulates ERK and JNK signal pathways. J Biol Chem 277: 6490-6496, 2002. (Pubitemid 34968446)
16. Langzam L, Koren R, Gal R, Kugel V, Paz A, Farkas A and Sampson SR: Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relations to degree of malignancy. Am J Clin Path 116: 377-385, 2001. (Pubitemid 32851971)
17. Meldrum DR, Cleveland JC Jr, Meng X, Sheridan BC, Cain BS, Gamboni F, Harken AH and Banerjee A: Protein kinase C isoform diversity in preconditioning. J Surg Res 69: 183-187, 1997. (Pubitemid 27265847)
18. Delannoy P, Lemonnier J, Hay E, Modrowski D and Marie PJ: Protein kinase C-dependent upregulation of N-cadherin expression by phorbol ester in human calvaria osteoblasts. Exp Cell Res 269: 154-161, 2001. (Pubitemid 32848498)
19. 2α stimulates tyrosine phosphorylation and mitogen-activated protein kinase C activation. Endocrology 138: 1821-1828, 1997.
20. Sanders J and Stern P: Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts. J Bone Miner Res 11: 1862-1872, 1996.
21. Lampasso JD, Intini G and Dziak M: Effects of 1,25 Dihydroxyvitamin D3 on PKC isoform expression in osteoblastic cells. Int J Oral Biol 25: 65-73, 2000.
22. Lampasso JD, Marzec N, Margarone J and Dziak M: Sphingosine-1-phosphate effects on PKC isoform in human osteoblastic cells. Prostaglandins Leukot Essent Fatty Acids 3: 1139-1146, 2001.
23. Sakai T, Okano Y, Nozawa Y and Oka N: Different Protein kinase C isozymes could modulate bradykinin-induced extracellular calcium-dependent and -independent increases in osteoblast-like MC3T3-E1 cells. Cell Calcium 13: 329-340, 1992.
24. Bessey O, Lowry OH and Brock MJ: A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 164: 321-325, 1946.
25. D'Alonzo RC, Kowalski AJ, Denhart DT, Nickols GA and Partridge NC: Regulation of Collagenase-3 and osteocalcin gene expression by collagen and osteopontin in differentiating MC3T3-E1 cells. J Biol Chem 277: 24788-24798, 2002.
26. Vary CPH, Li V, Raouf A, Kitching R, Ismail K, Franceschi C, Venanzoni M and Seth A: Involvement of Ets transcription factors and targets in osteoblast differentiation and matrix mineralization. Exp Cell Res 257: 213-222, 2000. (Pubitemid 30324660)
27. Mathews SA, Rozengurt E and Cantrell D: Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J Exp Med 191: 2075-2082, 2000. (Pubitemid 30416354)
28. Asado A, Zhao Y and Kondo S: Iwata M. Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J Biol Chem 273: 28392-28398, 1998. (Pubitemid 28496143)
29. Chen CC, Wang JK and Lin SB: Antisense oligonucleotides targeting protein kinase C-α, -β1, or -δ but not -η inhibit lipopolysacharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear tactor kB-dependent mechanism. J Immunol 161: 6206-6214, 1998.
30. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW 2nd and Mochly-Rosen D: Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci USA 98: 11114-11119, 2001.
31. Lampasso JD, Marzec N, Margarone J and Dziak M: Role of protein kinace C-α in primary human osteoblast proliferation. J Biomed Mater Res 17: 1968-1976, 2002.
32. Geng WD, Boskovic G, Fultz ME, Li C, Niles RM, Ohno S and Wright GL: Regulation of expression and activity of four PKC isozymes in confluent and mechanically stimulated UMR-108 osteoblastic cells. J Cell Physiol 189: 216-228, 2001.
33. Beck GR, Zerler B and Moran E: Gene array analysis of osteoblast differentiation. Cell Growth Differ 12: 61-83, 2001. (Pubitemid 32194897)
34. Hu Y, Chan E, Wang SX and Li B: Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144: 2068-2074, 2003. (Pubitemid 36543347)
35. Cabodi S, Calautti E, Talora C, Kuroki T, Stein PL and Dotto GP: A PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. Mol Cell 6: 1121-1129, 2000.
36. Livneh E, Shimon T, Bechor E, Doki Y, Schieren I and Weinstein IB: Linking protein kinase C to the cell cycle: ectopic expression of PKC eta in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis. Oncogene 12: 1545-1555, 1996. (Pubitemid 26132041)